Current Research into Cures for Type-1 Diabetes

Ustekinumab Is Fully Enrolled Ustekinumab, an immune modulating drug, started a Phase-II? trial in July 2014.  I previously blogged about...

Golimumab (sold as Simponi) is an immune system modulator, which has been approved in the United States and many other countries for treatme...

In the US, we are in the "Walking Season" when JDRF asks us to walk to raise money for a cure. So I'd like to do my part, by r...

These researchers are running a three-armed clinical trial.  One group will get two drugs: Vildagliptin and Rapamycin.  Another group will ...

Substance P is a peptide (a part of a protein) which is used by several different organs and for several different purposes.   Research done...

You'll notice that the title of this blog refers to a "Phase-II?" trial, rather than the more usual "Phase-II"  tria...

Atrovastatin (much better known as Lipitor) has now finished it's second phase-II trial.  The previous trial was unsuccessful, and this...